{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T16:19:39Z","timestamp":1780589979904,"version":"3.54.1"},"reference-count":68,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","sfnmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Fetal and Neonatal Medicine"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.siny.2019.04.006","type":"journal-article","created":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T11:57:43Z","timestamp":1554724663000},"page":"207-212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Alternatives to systemic postnatal corticosteroids: Inhaled, nebulized and intratracheal"],"prefix":"10.1016","volume":"24","author":[{"given":"Christoph M.","family":"R\u00fcegger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Bassler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.siny.2019.04.006_bib1","first-page":"Cd001146","article-title":"Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants","volume":"10","author":"Doyle","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.siny.2019.04.006_bib2","doi-asserted-by":"crossref","first-page":"e106838","DOI":"10.1371\/journal.pone.0106838","article-title":"Utilization of inhaled corticosteroids for infants with bronchopulmonary dysplasia","volume":"9","author":"Slaughter","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.siny.2019.04.006_bib3","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1159\/000316978","article-title":"Survey of practices regarding utilization of inhaled steroids in 223 German neonatal units","volume":"98","author":"Maas","year":"2010","journal-title":"Neonatology"},{"key":"10.1016\/j.siny.2019.04.006_bib4","doi-asserted-by":"crossref","first-page":"F371","DOI":"10.1136\/archdischild-2014-308060","article-title":"Current UK practices in steroid treatment of chronic lung disease","volume":"100","author":"Job","year":"2015","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.siny.2019.04.006_bib5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/ped.12584","article-title":"Drug treatment for bronchopulmonary dysplasia in Japan: questionnaire survey","volume":"57","author":"Ogawa","year":"2015","journal-title":"Pediatr Int: Off J Japan Pediatr Soc"},{"key":"10.1016\/j.siny.2019.04.006_bib6","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1165\/rcmb.2016-0068OC","article-title":"Antiinflammatory effects of budesonide in human fetal lung","volume":"55","author":"Barrette","year":"2016","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.siny.2019.04.006_bib7","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1053\/siny.2001.0069","article-title":"Postnatal glucocorticoid therapy for prevention of bronchopulmonary dysplasia: routes of administration compared","volume":"6","author":"Cole","year":"2001","journal-title":"Semin Neonatol: SN"},{"key":"10.1016\/j.siny.2019.04.006_bib8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/1099-0496(200010)30:4<275::AID-PPUL1>3.0.CO;2-G","article-title":"Effects of early inhaled beclomethasone therapy on tracheal aspirate inflammatory mediators IL-8 and IL-1ra in ventilated preterm infants at risk for bronchopulmonary dysplasia","volume":"30","author":"Gupta","year":"2000","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.siny.2019.04.006_bib9","first-page":"78","article-title":"Postnatal steroids in extreme preterm infants: intra-tracheal instillation using surfactant as a vehicle","volume":"25","author":"Boel","year":"2018","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.siny.2019.04.006_bib10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1875-9572(10)60042-3","article-title":"Acute pathophysiological effects of intratracheal instillation of budesonide and exogenous surfactant in a neonatal surfactant-depleted piglet model","volume":"51","author":"Yang","year":"2010","journal-title":"Pediatr Neonatol"},{"key":"10.1016\/j.siny.2019.04.006_bib11","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00431-010-1292-6","article-title":"Aerosol delivery to ventilated newborn infants: historical challenges and new directions","volume":"170","author":"Mazela","year":"2011","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.siny.2019.04.006_bib12","first-page":"609","article-title":"Nebulizers: principles and performance","volume":"45","author":"Hess","year":"2000","journal-title":"Respir Care"},{"issue":"Suppl A","key":"10.1016\/j.siny.2019.04.006_bib13","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1016\/S1526-0542(04)90019-X","article-title":"Inhaled corticosteroids: devices and deposition","volume":"5","author":"Rubin","year":"2004","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.siny.2019.04.006_bib14","first-page":"1177","article-title":"Principles of metered-dose inhaler design","volume":"50","author":"Newman","year":"2005","journal-title":"Respir Care"},{"key":"10.1016\/j.siny.2019.04.006_bib15","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.jaci.2010.01.034","article-title":"Factors that affect the efficacy of inhaled corticosteroids for infants and young children","volume":"125","author":"Amirav","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.siny.2019.04.006_bib16","first-page":"916","article-title":"Aerosol consensus statement--1991. American association for respiratory care","volume":"36","year":"1991","journal-title":"Respir Care"},{"key":"10.1016\/j.siny.2019.04.006_bib17","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/(SICI)1099-0496(199605)21:5<301::AID-PPUL5>3.0.CO;2-P","article-title":"Efficiency of aerosol medication delivery from a metered dose inhaler versus jet nebulizer in infants with bronchopulmonary dysplasia","volume":"21","author":"Fok","year":"1996","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.siny.2019.04.006_bib18","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1164\/ajrccm.149.1.8111585","article-title":"Aerosol deposition in mechanically ventilated patients. Optimizing nebulizer delivery","volume":"149","author":"O'Riordan","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.siny.2019.04.006_bib19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1203\/PDR.0b013e318175dcfa","article-title":"Development of the premature infant nose throat-model (PrINT-Model): an upper airway replica of a premature neonate for the study of aerosol delivery","volume":"64","author":"Minocchieri","year":"2008","journal-title":"Pediatr Res"},{"key":"10.1016\/j.siny.2019.04.006_bib20","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/(SICI)1099-0496(199710)24:4<282::AID-PPUL7>3.0.CO;2-M","article-title":"Jet nebulization of budesonide suspension into a neonatal ventilator circuit: synchronized versus continuous nebulizer flow","volume":"24","author":"Pelkonen","year":"1997","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.siny.2019.04.006_bib21","first-page":"419","article-title":"A\u00a0novel, versatile valved holding chamber for delivering inhaled medications to neonates and small children: laboratory simulation of delivery options","volume":"55","author":"DiBlasi","year":"2010","journal-title":"Respir Care"},{"key":"10.1016\/j.siny.2019.04.006_bib22","first-page":"1029","article-title":"Albuterol delivery from a metered-dose inhaler with spacer is reduced following short-duration manual ventilation in a neonatal ventilator-lung model","volume":"49","author":"Lugo","year":"2004","journal-title":"Respir Care"},{"key":"10.1016\/j.siny.2019.04.006_bib23","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/ppul.1035","article-title":"Albuterol delivery in a neonatal ventilated lung model: nebulization versus chlorofluorocarbon- and hydrofluoroalkane-pressurized metered dose inhalers","volume":"31","author":"Lugo","year":"2001","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.siny.2019.04.006_bib24","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/adc.65.4.401","article-title":"How much aerosol reaches the lungs of wheezy infants and toddlers?","volume":"65","author":"Salmon","year":"1990","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.siny.2019.04.006_bib25","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1183\/09031936.94.07122185","article-title":"The influence of age on aerosol deposition in children with cystic fibrosis","volume":"7","author":"Chua","year":"1994","journal-title":"Eur Respir J"},{"key":"10.1016\/j.siny.2019.04.006_bib26","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/(SICI)1099-0496(199605)21:5<276::AID-PPUL2>3.0.CO;2-L","article-title":"Aerosol deposition in infants with cystic fibrosis","volume":"21","author":"Mallol","year":"1996","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.siny.2019.04.006_bib27","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1136\/adc.88.8.719","article-title":"Nebuliser hood compared to mask in wheezy infants: aerosol therapy without tears!","volume":"88","author":"Amirav","year":"2003","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.siny.2019.04.006_bib28","first-page":"487","article-title":"Beta-agonist aerosol distribution in respiratory syncytial virus bronchiolitis in infants","volume":"43","author":"Amirav","year":"2002","journal-title":"J\u00a0Nucl Med: Off Publ Soc Nucl Med"},{"key":"10.1016\/j.siny.2019.04.006_bib29","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0022-3476(96)70357-8","article-title":"Deposition pattern of radiolabeled salbutamol inhaled from a metered-dose inhaler by means of a spacer with mask in young children with airway obstruction","volume":"128","author":"Tal","year":"1996","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.siny.2019.04.006_bib30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/0894268041457228","article-title":"Deposition of aerosols in infants and children","volume":"17","author":"Schuepp","year":"2004","journal-title":"J\u00a0Aerosol Med: Off J Int Soc Aero Med"},{"key":"10.1016\/j.siny.2019.04.006_bib31","first-page":"175","article-title":"Aerosol therapy for children","volume":"7","author":"Rubin","year":"2001","journal-title":"Respir Care Clin"},{"key":"10.1016\/j.siny.2019.04.006_bib32","first-page":"CD001969","article-title":"Early administration of inhaled corticosteroids for preventing chronic lung disease in very low birth weight preterm neonates","author":"Shah","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.siny.2019.04.006_bib33","first-page":"CD002311","article-title":"Late (>= 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants","volume":"8","author":"Onland","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.siny.2019.04.006_bib34","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-2511","article-title":"Inhaled corticosteroids for bronchopulmonary dysplasia: a meta-analysis","volume":"138","author":"Shinwell","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.siny.2019.04.006_bib35","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000227294","article-title":"The Neonatal European Study of Inhaled Steroids (NEUROSIS): an eu-funded international randomised controlled trial in preterm infants","volume":"97","author":"Bassler","year":"2010","journal-title":"Neonatology"},{"key":"10.1016\/j.siny.2019.04.006_bib36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/pch\/7.1.13","article-title":"Early prophylactic inhaled beclomethasone in infants less than 1250 g for the prevention of chronic lung disease","volume":"7","author":"Jangaard","year":"2002","journal-title":"Paediatr Child Health"},{"key":"10.1016\/j.siny.2019.04.006_bib37","doi-asserted-by":"crossref","first-page":"F552","DOI":"10.1136\/archdischild-2015-309943","article-title":"Early inhaled steroid use in extremely low birthweight infants: a randomised controlled trial","volume":"101","author":"Nakamura","year":"2016","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.siny.2019.04.006_bib38","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1056\/NEJMoa1708831","article-title":"Long-term effects of inhaled budesonide for bronchopulmonary dysplasia","volume":"378","author":"Bassler","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.siny.2019.04.006_bib39","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1056\/NEJMoa1501917","article-title":"Early inhaled budesonide for the prevention of bronchopulmonary dysplasia","volume":"373","author":"Bassler","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.siny.2019.04.006_bib40","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/apa.14180","article-title":"Are inhaled steroids safe and effective for prevention or treatment of bronchopulmonary dysplasia?","volume":"107","author":"Shinwell","year":"2018","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.siny.2019.04.006_bib41","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/sj.jp.7210705","article-title":"A\u00a0randomized trial of inhaled versus intravenous steroids in ventilator-dependent preterm infants","volume":"22","author":"Suchomski","year":"2002","journal-title":"J\u00a0Perinatol"},{"key":"10.1016\/j.siny.2019.04.006_bib42","doi-asserted-by":"crossref","first-page":"e566","DOI":"10.1542\/peds.2004-0951","article-title":"Fluticasone inhalation in moderate cases of bronchopulmonary dysplasia","volume":"115","author":"Dugas","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.siny.2019.04.006_bib43","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF02752304","article-title":"Respiratory and systemic effects of inhaled dexamethasone on ventilator dependant preterm infants at risk for bronchopulmonary dysplasia","volume":"65","author":"Pappagallo","year":"1998","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.siny.2019.04.006_bib44","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0022-3476(96)70204-4","article-title":"A\u00a0trial of the safety of inhaled beclomethasone in ventilator-treated neonates","volume":"129","author":"Liu","year":"1996","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.siny.2019.04.006_bib45","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1080\/14767058.2016.1248937","article-title":"Inhaled budesonide for the prevention of bronchopulmonary dysplasia","volume":"30","author":"Bassler","year":"2017","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.siny.2019.04.006_bib46","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1164\/ajrccm.157.3.157315","article-title":"Efficacy and safety of inhaled corticosteroids. New developments","volume":"157","author":"Barnes","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.siny.2019.04.006_bib47","doi-asserted-by":"crossref","first-page":"e0192162","DOI":"10.1371\/journal.pone.0192162","article-title":"Neonatal corticosteroid therapy affects growth patterns in early infancy","volume":"13","author":"Tijsseling","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.siny.2019.04.006_bib48","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1210\/jcem.83.7.4947","article-title":"Pituitary-adrenal suppression in preterm, very low birth weight infants after inhaled fluticasone propionate treatment","volume":"83","author":"Ng","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.siny.2019.04.006_bib49","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0022-3476(99)70329-X","article-title":"Adrenal function in premature infants during inhaled beclomethasone therapy","volume":"135","author":"Cole","year":"1999","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.siny.2019.04.006_bib50","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1056\/NEJMe1509243","article-title":"No end to uncertainty about inhaled glucocorticoids in preterm infants","volume":"373","author":"Schmidt","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.siny.2019.04.006_bib51","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000468507","article-title":"Inhaled glucocorticoids and pneumonia in preterm infants: post hoc results from the NEuroSIS trial","volume":"112","author":"Koch","year":"2017","journal-title":"Neonatology"},{"key":"10.1016\/j.siny.2019.04.006_bib52","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1164\/rccm.201509-1830ED","article-title":"Prevention of bronchopulmonary dysplasia: are intratracheal steroids with surfactant a magic bullet?","volume":"193","author":"Bancalari","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.siny.2019.04.006_bib53","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1164\/ajrccm\/144.4.909","article-title":"Pulmonary surfactant as a vehicle for intratracheal delivery of technetium sulfur colloid and pentamidine in hamster lungs","volume":"144","author":"Kharasch","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.siny.2019.04.006_bib54","doi-asserted-by":"crossref","first-page":"E1310","DOI":"10.1542\/peds.2007-1973","article-title":"Early intratracheal instillation of budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants: a pilot study","volume":"121","author":"Yeh","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.siny.2019.04.006_bib55","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1164\/rccm.201505-0861OC","article-title":"Intratracheal administration of budesonide\/surfactant to prevent bronchopulmonary dysplasia","volume":"193","author":"Yeh","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.siny.2019.04.006_bib56","doi-asserted-by":"crossref","first-page":"S175","DOI":"10.1016\/S0091-6749(99)70059-X","article-title":"Pharmacodynamics and pharmacokinetics of budesonide: a new nebulized corticosteroid","volume":"104","author":"Szefler","year":"1999","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.siny.2019.04.006_bib57","first-page":"623","article-title":"Reversible fatty acid conjugation of budesonide. Novel mechanism for prolonged retention of topically applied steroid in airway tissue","volume":"26","author":"Miller-Larsson","year":"1998","journal-title":"Drug Metab Dispos: Biol Fate Chem"},{"key":"10.1016\/j.siny.2019.04.006_bib58","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1046\/j.1440-1681.2002.03712.x","article-title":"Intratracheal administration of glucocorticoids using surfactant as a vehicle","volume":"29","author":"Nimmo","year":"2002","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.siny.2019.04.006_bib59","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.pedneo.2014.04.009","article-title":"Effect of surfactant and budesonide on the pulmonary distribution of fluorescent dye in mice","volume":"56","author":"Huang","year":"2015","journal-title":"Pediatr Neonatol"},{"key":"10.1016\/j.siny.2019.04.006_bib60","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0927-7765(96)01286-6","article-title":"Lipid perturbation by corticosteroids: an anisotropic study","volume":"7","author":"Ghosh","year":"1996","journal-title":"Colloids Surfaces B Biointerfaces"},{"key":"10.1016\/j.siny.2019.04.006_bib61","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1095-6433(01)00307-5","article-title":"The roles of cholesterol in pulmonary surfactant: insights from comparative and evolutionary studies","volume":"129","author":"Orgeig","year":"2001","journal-title":"Comp Biochem Physiol Mol Integr Physiol"},{"key":"10.1016\/j.siny.2019.04.006_bib62","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1529\/biophysj.106.099762","article-title":"Effect of cholesterol on the biophysical and physiological properties of a clinical pulmonary surfactant","volume":"93","author":"Keating","year":"2007","journal-title":"Biophys J"},{"key":"10.1016\/j.siny.2019.04.006_bib63","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.bbalip.2005.09.002","article-title":"Pulmonary surfactant function is abolished by an elevated proportion of cholesterol","volume":"1737","author":"Gunasekara","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.siny.2019.04.006_bib64","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1152\/jappl.2000.89.3.884","article-title":"Effect of budesonide and salbutamol on surfactant properties","volume":"89","author":"Palmer","year":"2000","journal-title":"J\u00a0Appl Physiol"},{"key":"10.1016\/j.siny.2019.04.006_bib65","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/pr.2011.78","article-title":"Differential effects of cholesterol and budesonide on biophysical properties of clinical surfactant","volume":"71","author":"Zhang","year":"2012","journal-title":"Pediatr Res"},{"key":"10.1016\/j.siny.2019.04.006_bib66","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.resp.2016.07.009","article-title":"Analysis of the structure and surfactant activity of novel formulations containing exogenous pulmonary surfactant and glucocorticoids","volume":"233","author":"Cimato","year":"2016","journal-title":"Respir Physiol Neurobiol"},{"key":"10.1016\/j.siny.2019.04.006_bib67","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jpeds.2009.10.049","article-title":"A\u00a0follow-up study of preterm infants given budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants","volume":"156","author":"Kuo","year":"2010","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.siny.2019.04.006_bib68","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/ppul.23680","article-title":"Intratracheal administration of budesonide-surfactant in prevention of bronchopulmonary dysplasia in very low birth weight infants: a systematic review and meta-analysis","volume":"52","author":"Venkataraman","year":"2017","journal-title":"Pediatr Pulmonol"}],"container-title":["Seminars in Fetal and Neonatal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1744165X19300368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1744165X19300368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:42:59Z","timestamp":1761676979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1744165X19300368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S1744165X19300368"],"URL":"https:\/\/doi.org\/10.1016\/j.siny.2019.04.006","relation":{},"ISSN":["1744-165X"],"issn-type":[{"value":"1744-165X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alternatives to systemic postnatal corticosteroids: Inhaled, nebulized and intratracheal","name":"articletitle","label":"Article Title"},{"value":"Seminars in Fetal and Neonatal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.siny.2019.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}